![]() 229940074393 Chlorogenic acid Drugs 0.000 abstract description 16.CWVRJTMFETXNAD-JUHZACGLSA-N Chlorogenic acid Chemical compound CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 abstract description 42.235000001368 chlorogenic acid Nutrition 0.000 abstract description 160.CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 abstract description 324.UFCLZKMFXSILNL-PSEXTPKNSA-N Isochlorogenic acid b Chemical compound UFCLZKMFXSILNL-PSEXTPKNSA-N 0.000 claims description 8.UFCLZKMFXSILNL-RVXRWRFUSA-N 4,5-Di-O-caffeoylquinic acid Chemical compound UFCLZKMFXSILNL-RVXRWRFUSA-N 0.000 claims description 8.UFCLZKMFXSILNL-AALYGJCLSA-N 3,4-Dicaffeoylquinic acid Natural products UFCLZKMFXSILNL-AALYGJCLSA-N 0.000 claims description 8.208000001072 Type 2 Diabetes Mellitus Diseases 0.000 claims description 32.230000002401 inhibitory effect Effects 0.000 claims description 102.102000003638 Glucose-6-Phosphatase Human genes 0.000 claims description 136.GYFFKZTYYAFCTR-JUHZACGLSA-N 4-O-trans-caffeoylquinic acid Chemical compound GYFFKZTYYAFCTR-JUHZACGLSA-N 0.000 claims abstract description 60.GYFFKZTYYAFCTR-AVXJPILUSA-N 4-Caffeoylquinic acid Natural products GYFFKZTYYAFCTR-AVXJPILUSA-N 0.000 claims abstract description 84.CWVRJTMFETXNAD-NXLLHMKUSA-N Neochlorogenic acid Chemical compound CWVRJTMFETXNAD-NXLLHMKUSA-N 0.000 claims abstract description 286.230000029964 regulation of glucose metabolic process Effects 0.000 title 2.230000037396 body weight Effects 0.000 title abstract description 24.239000000284 extract Substances 0.000 title abstract description 404.Assignors: DIKANSKY, JACQUES, IBARRA, ALVIN, ROLLER, MARC Publication of US20150072042A2 publication Critical patent/US20150072042A2/en Publication of US20160015766A2 publication Critical patent/US20160015766A2/en Priority to US15/173,765 priority patent/US10092613B2/en Application granted granted Critical Publication of US9358264B2 publication Critical patent/US9358264B2/en Status Active legal-status Critical Current Adjusted expiration legal-status Critical Links ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US12/263,292 external-priority patent/US20100112098A1/en Application filed by Naturex SA filed Critical Naturex SA Priority to US13/072,648 priority Critical patent/US9358264B2/en Publication of US20110223281A1 publication Critical patent/US20110223281A1/en Assigned to Naturex, S.A. Original Assignee Naturex SA Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ![]() ( en Inventor Alvin Ibarra Marc Roller Jacques Dikansky Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active, expires Application number US13/072,648 Other versions US20110223281A1 Google Patents Effects of a decaffeinated green coffee extract on body weight control by regulation of glucose metabolismÄownload PDF Info Publication number US9358264B2 US9358264B2 US13/072,648 US201113072648A US9358264B2 US 9358264 B2 US9358264 B2 US 9358264B2 US 201113072648 A US201113072648 A US 201113072648A US 9358264 B2 US9358264 B2 US 9358264B2 Authority US United States Prior art keywords green coffee coffee extract cqa svetol acid Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US9358264B2 - Effects of a decaffeinated green coffee extract on body weight control by regulation of glucose metabolism US9358264B2 - Effects of a decaffeinated green coffee extract on body weight control by regulation of glucose metabolism ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |